A physician evaluates an ambulatory patient who recently developed a progressively worsening rash on both lower extremities. The patient also reports significant new-onset fatigue and bilateral pain in the metacarpophalangeal and knee joints over the past days. Medical history is significant for a diagnosis of chronic hepatitis C virus (HCV) infection confirmed several years ago, though the patient has not undergone any targeted antiviral treatment. On physical examination, the physician notes multiple non-blanching, raised, red-purple lesions distributed over the shins and calves. Joint examination shows mild, symmetric swelling without warmth. Laboratory analysis demonstrates the following:
Serum aspartate aminotransferase: U/L
Serum alanine aminotransferase: U/L
Rheumatoid factor: Positive
Complement C3: Normal
Complement C4: Markedly decreased
Urinalysis: protein, - red blood cells/hpf, occasional dysmorphic red blood cells
Which of the following immunopathologic mechanisms is most likely responsible for this patient's current clinical presentation?
- AAutoantibody binding to platelet surface glycoproteins with subsequent splenic macrophage destruction
- BNeutrophil activation by autoantibodies directed against cytoplasmic lysosomal enzymes
- Precipitation and vessel wall deposition of circulating immune complexes containing IgG and IgMAnswer
- DSystemic activation of the coagulation cascade resulting in microvascular fibrin thrombi
- ETransmural inflammation and fibrinoid necrosis of medium-sized muscular arteries